List of Natco Pharma patents

Patents where

Current Assignee

Name

‌

Natco Pharma

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 9440959 Process for the preparation of nilotinib	Patent 9440959 was granted and assigned to Natco Pharma on September, 2016 by the United States Patent and Trademark Office.	‌ Natco Pharma	‌ Natco Pharma	United States Patent and Trademark Office	9440959	September 13, 2016
‌ US Patent 10106554 7-(morpholinyl)-2-(N-piperazinyl) methyl thieno [2, 3-C] pyridine derivatives as anticancer drugs	Patent 10106554 was granted and assigned to Natco Pharma on October, 2018 by the United States Patent and Trademark Office.	‌ Natco Pharma	‌ Natco Pharma	United States Patent and Trademark Office	10106554	October 23, 2018
‌ US Patent 11008296 Intermediates for the preparation of eribulin thereof	Patent 11008296 was granted and assigned to Natco Pharma on May, 2021 by the United States Patent and Trademark Office.	‌ Natco Pharma	‌ Natco Pharma	United States Patent and Trademark Office	11008296	May 18, 2021
‌ US Patent 9061028 Process for the preparation of Nilotinib	Patent 9061028 was granted and assigned to Natco Pharma on June, 2015 by the United States Patent and Trademark Office.		‌ Natco Pharma	United States Patent and Trademark Office	9061028	June 23, 2015
‌ US Patent 9481655 6,7-dialkoxy quinazoline derivatives and methods of treating drug resistant and other tumors	Patent 9481655 was granted and assigned to Natco Pharma on November, 2016 by the United States Patent and Trademark Office.	‌ Natco Pharma	‌ Natco Pharma	United States Patent and Trademark Office	9481655	November 1, 2016
‌ US Patent 8080558 4-(tetrazol-5-yl)-quinazoline derivatives as anti-cancer agent	Patent 8080558 was granted and assigned to Natco Pharma on December, 2011 by the United States Patent and Trademark Office.		‌ Natco Pharma	United States Patent and Trademark Office	8080558	December 20, 2011
‌ US Patent 10047088 1H-1,8-naphthyridin-2-ones as anti proliferative compounds	Patent 10047088 was granted and assigned to Natco Pharma on August, 2018 by the United States Patent and Trademark Office.	‌ Natco Pharma	‌ Natco Pharma	United States Patent and Trademark Office	10047088	August 14, 2018
‌ US Patent 8048883 Polymorphic form of imatinib mesylate and a process for its preparation	Patent 8048883 was granted and assigned to Natco Pharma on November, 2011 by the United States Patent and Trademark Office.		‌ Natco Pharma	United States Patent and Trademark Office	8048883	November 1, 2011
‌ US Patent 11111228 Process for the preparation of pomalidomide and its purification	Patent 11111228 was granted and assigned to Natco Pharma on September, 2021 by the United States Patent and Trademark Office.	‌ Natco Pharma	‌ Natco Pharma	United States Patent and Trademark Office	11111228	September 7, 2021
‌ US Patent 8735415 Acid addition salts of (3,5-Bis trifluoromethyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2ylamino)-phenyl]-benzamide	Patent 8735415 was granted and assigned to Natco Pharma on May, 2014 by the United States Patent and Trademark Office.		‌ Natco Pharma	United States Patent and Trademark Office	8735415	May 27, 2014
‌ US Patent 9365880 Fermentation process for the production of rapamycin	Patent 9365880 was granted and assigned to Natco Pharma on June, 2016 by the United States Patent and Trademark Office.		‌ Natco Pharma	United States Patent and Trademark Office	9365880	June 14, 2016
‌ US Patent 9895367 Formulation comprising phenylaminopyrimidine derivative as active agent	Patent 9895367 was granted and assigned to Natco Pharma on February, 2018 by the United States Patent and Trademark Office.		‌ Natco Pharma	United States Patent and Trademark Office	9895367	February 20, 2018
‌ US Patent 11091470 Process for the preparation of N-(3-ethynylphenyl)-7-methoxy-6-(3-morpholinopropoxy) quinazolin-4-amine dihydrochloride	Patent 11091470 was granted and assigned to Natco Pharma on August, 2021 by the United States Patent and Trademark Office.	‌ Natco Pharma	‌ Natco Pharma	United States Patent and Trademark Office	11091470	August 17, 2021
‌ US Patent 8993722 Process for the preparation glatiramer acetate (copolymer-1)	Patent 8993722 was granted and assigned to Natco Pharma on March, 2015 by the United States Patent and Trademark Office.		‌ Natco Pharma	United States Patent and Trademark Office	8993722	March 31, 2015
‌ US Patent 8143250 6-7,dialkoxy quinazoline derivatives useful for treatment of cancer related disorders	Patent 8143250 was granted and assigned to Natco Pharma on March, 2012 by the United States Patent and Trademark Office.		‌ Natco Pharma	United States Patent and Trademark Office	8143250	March 27, 2012
‌ US Patent 8664389 Process for the preparation of lapatinib and it's pharmaceutically acceptable salts	Patent 8664389 was granted and assigned to Natco Pharma on March, 2014 by the United States Patent and Trademark Office.		‌ Natco Pharma	United States Patent and Trademark Office	8664389	March 4, 2014
‌ US Patent 8466190 Polymorphic forms of Sunitinib base	Patent 8466190 was granted and assigned to Natco Pharma on June, 2013 by the United States Patent and Trademark Office.		‌ Natco Pharma	United States Patent and Trademark Office	8466190	June 18, 2013
‌ US Patent 11465988 Process for the preparation of Tipiracil hydrochloride and intermediates thereof	Patent 11465988 was granted and assigned to Natco Pharma on October, 2022 by the United States Patent and Trademark Office.	‌ Natco Pharma	‌ Natco Pharma	United States Patent and Trademark Office	11465988	October 11, 2022
‌ US Patent 7960545 Process for the prepartion of erlotinib	Patent 7960545 was granted and assigned to Natco Pharma on June, 2011 by the United States Patent and Trademark Office.		‌ Natco Pharma	United States Patent and Trademark Office	7960545	June 14, 2011
‌ US Patent 9108945 Anhydrous lenalidomide form-I	Patent 9108945 was granted and assigned to Natco Pharma on August, 2015 by the United States Patent and Trademark Office.	‌ Natco Pharma	‌ Natco Pharma	United States Patent and Trademark Office	9108945	August 18, 2015
‌ US Patent 8748602 Polymorphs of erlotinib hydrochloride and method of preparation	Patent 8748602 was granted and assigned to Natco Pharma on June, 2014 by the United States Patent and Trademark Office.	‌ Natco Pharma	‌ Natco Pharma	United States Patent and Trademark Office	8748602	June 10, 2014
‌ US Patent 9227948 Process for the preparation of 2-substituted-2-(6-(substituted)-7-methylbenzo[D][1,3]dioxol-4-yl)acetic acid derivatives	Patent 9227948 was granted and assigned to Natco Pharma on January, 2016 by the United States Patent and Trademark Office.	‌ Natco Pharma	‌ Natco Pharma	United States Patent and Trademark Office	9227948	January 5, 2016
‌ US Patent 11498902 Process for the preparation of Cabozantinib and its pharmaceutically acceptable salts thereof	Patent 11498902 was granted and assigned to Natco Pharma on November, 2022 by the United States Patent and Trademark Office.	‌ Natco Pharma	‌ Natco Pharma	United States Patent and Trademark Office	11498902	November 15, 2022
‌ US Patent 9750700 Imatinib mesylate oral pharmaceutical composition and process for preparation thereof	Patent 9750700 was granted and assigned to Natco Pharma on September, 2017 by the United States Patent and Trademark Office.		‌ Natco Pharma	United States Patent and Trademark Office	9750700	September 5, 2017
‌ US Patent 10870650 Process for the preparation of amorphous idelalisib		‌ Natco Pharma	‌ Natco Pharma	United States Patent and Trademark Office	10870650	December 22, 2020

Results per page:

45 results

0 selected

45 results

0 selected